Seqens Seqens

X

CAS 37743-18-3 manufacturers and suppliers on PharmaCompass

PharmaCompass
CAS 37743-18-3
Also known as: 37743-18-3, (3,3-diphenyldihydrofuran-2-ylidine)-dimethylammonium bromide, (3,3-diphenyloxolan-2-ylidene)-dimethylazanium;bromide, (3,3-diphenyldihydrofuran-2-ylidine)dimethylammoniumbromide, Dihydro-n,n-dimethyl-3,3-diphenyl-2(3h)-furaniminium bromide, Dimethyl(tetrahydro-3,3-diphenyl-2-furylidene)ammonium bromide
Molecular Formula
C18H20BrNO
Molecular Weight
346.3  g/mol
InChI Key
QJPXLCQSAFQCBD-UHFFFAOYSA-M

1 2D Structure

CAS 37743-18-3

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
(3,3-diphenyloxolan-2-ylidene)-dimethylazanium;bromide
2.1.2 InChI
InChI=1S/C18H20NO.BrH/c1-19(2)17-18(13-14-20-17,15-9-5-3-6-10-15)16-11-7-4-8-12-16;/h3-12H,13-14H2,1-2H3;1H/q+1;/p-1
2.1.3 InChI Key
QJPXLCQSAFQCBD-UHFFFAOYSA-M
2.1.4 Canonical SMILES
C[N+](=C1C(CCO1)(C2=CC=CC=C2)C3=CC=CC=C3)C.[Br-]
2.2 Synonyms
2.2.1 Depositor-Supplied Synonyms

1. 37743-18-3

2. (3,3-diphenyldihydrofuran-2-ylidine)-dimethylammonium Bromide

3. (3,3-diphenyloxolan-2-ylidene)-dimethylazanium;bromide

4. (3,3-diphenyldihydrofuran-2-ylidine)dimethylammoniumbromide

5. Dihydro-n,n-dimethyl-3,3-diphenyl-2(3h)-furaniminium Bromide

6. Dimethyl(tetrahydro-3,3-diphenyl-2-furylidene)ammonium Bromide

7. Dimethyl-(tetrahydro-3,3-diphenyl-2-furilidine)ammonium Bromide

8. 5-(dimethylamino)-4,4-diphenyl-3,4-dihydro-2h-furan-1-ium Bromide

9. Mfcd02093792

10. Methanaminium,n-(dihydro-3,3-diphenyl-2(3h)-furanylidene)-n-methyl-, Bromide

11. (dihydro-3,3-diphenyl-3h-furan-2-ylidene)dimethylammonium Bromide

12. Loperamide Impurity

13. Einecs 253-649-9

14. Mls006010009

15. Schembl461361

16. (3,3-diphenyloxolan-2-ylidene)-dimethylazanium,bromide

17. Dtxsid80958777

18. Akos005254480

19. As-12330

20. Smr004701090

21. Db-017956

22. Cs-0451890

23. Ft-0639403

24. A924213

25. W-106517

26. Dimethyl (tetrahydro-3,3-diphenyl-2-furylidene)ammonium Bromide

27. Dimethyl-(tetrahydro-3,3-diphenyl-2-furylidene)ammonium Bromide

28. Dimethyl (tetrahydro-3,3-diphenyl-2-furylidene) Ammonium Bromide

29. Dimethyl(tetrahydro-3,3-diphenyl-2-furylidene)ammonium Bromide Salt

30. N-(3,3-diphenylfuran-2(3h)-ylidene)-n-methylmethanaminium Bromide

31. N-(dihydro-3,3-diphenyl-2(3h)-furanylidene)-n-methylmethanaminium Bromide

2.3 Create Date
2005-07-19
3 Chemical and Physical Properties
Molecular Weight 346.3 g/mol
Molecular Formula C18H20BrNO
Hydrogen Bond Donor Count0
Hydrogen Bond Acceptor Count2
Rotatable Bond Count2
Exact Mass345.07283 g/mol
Monoisotopic Mass345.07283 g/mol
Topological Polar Surface Area12.2 Ų
Heavy Atom Count21
Formal Charge0
Complexity340
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count2
Flag India
Digital Content Digital Content
37743-18-3
Tagoor Laboratories, established in 2018, is a part of the Tagoor Group. It specializes in providing APIs...
Tagoor Laboratories, established in 2018, is a part of the Tagoor Group. It specializes in providing APIs, advanced intermediates and key starting materials for critical and high-growth therapeutic areas, with an emphasis on affordability, quality and timely delivery. It also provides end-to-end CDMO services. Headquartered in Hyderabad, Tagoor Labs is a fast-growing Indian pharma company that serves both branded and generic companies worldwide. The company’s organizational function includes R&D, supply chain, manufacturing, quality testing, quality assurance, regulatory affairs, marketing & sales, and packaging & warehousing departments.
Flag India
Digital Content Digital Content
URL Supplier Web Content
37743-18-3
VASUDHA PHARMA CHEM LIMITED was incorporated, as a public limited company under the Companies Act, 1956 i...
VASUDHA PHARMA CHEM LIMITED was incorporated, as a public limited company under the Companies Act, 1956 in 1994-95 at Hyderabad in the state of Telangana, India. The company is engaged in the manufacturing of Active Pharmaceutical Ingredients (APIs), Pharma Intermediates for catering to the Global market. Initially, the focus was on the development of cost effective processes for several intermediates related to piperidone & piperidine derivatives. By 2003-04, the company gained world class expertise and became the largest manufacturer of piperidone & piperidine derivatives in the world.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY